Latest Financial Results

Investor Relations

Mar 11, 2025 • 7:30 AM EDT

FY 2024 Year End Results

Fiscal Year Ended Dec 31, 2024

Earnings Release
PDF HTML
Earnings Webcast
Audio
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Latest News

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

Read Press Release View All News

Latest Presentation

Achieve Corporate Presentation 2025

View Presentation View All Presentations

Recent Events

Barclays 27th Annual Global Healthcare Conference

View Event View All Events

Latest Financial Results

FY 2024

Fiscal Year Ended Dec 31, 2024
Earnings Release
PDF HTML
Earnings Webcast
Audio
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2024

Report Links

Stock Snapshot

Company Overview

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

View Management Team View Board of Directors

IR Contacts

Company

Achieve Life Sciences, Inc.
22722 29th Dr. SE
Suite 100
Bothell, WA 98021
United States
T: 425-686-1500

Investor Relations

Nicole Jones
T: 425-686-1510
ir@achievelifesciences.com